What is a non-expandable lung?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Non-Expandable Lung?

Non-expandable lung is a mechanical complication where the lung cannot expand to the chest wall after pleural fluid drainage, preventing normal apposition between the visceral and parietal pleura. 1, 2

Underlying Mechanisms

The inability of the lung to expand results from visceral pleural disease processes that create a restrictive barrier. 1, 2 This occurs through two distinct pathophysiologic entities:

Lung Entrapment

  • Active pleural inflammation, infection, or malignancy causes visceral pleural involvement that prevents expansion 2, 3
  • The underlying disease process (malignant pleural effusion, empyema, complicated parapneumonic effusion) is the primary clinical problem 2, 3
  • This condition is potentially reversible if appropriate therapeutic measures are taken early 4

Trapped Lung

  • A mature fibrous membrane (pleural peel) overlies the visceral pleura from remote pleural inflammation 2, 3
  • This represents defective healing of the pleural space and is typically irreversible 2
  • Presents as a chronic, stable pleural effusion without evidence of active pleural disease 2
  • The mechanical effect of the pleural peel itself constitutes the primary clinical problem 3

Clinical Presentation

Non-expandable lung manifests in two characteristic ways during pleural drainage:

  • Post-thoracentesis hydropneumothorax develops when fluid is removed but the lung cannot expand to fill the space 2, 3, 4
  • Chest pain during drainage that prevents complete fluid removal 2, 3

Prevalence and Importance

At least 30% of patients with malignant pleural effusion have non-expandable lung, making this a common complication that fundamentally alters management strategy. 5, 6 Recognition is critical because:

  • Pleurodesis requires visceral and parietal pleural apposition to succeed, making it ineffective in non-expandable lung 5
  • Misrecognition leads to unnecessary procedures with significant cost and morbidity 1
  • Some patients will not experience symptomatic relief with pleural fluid removal 1

Diagnostic Approach

Clinical Recognition

  • Suspect when effusion cannot be completely drained due to anterior chest pain 2, 3
  • Consider when post-procedure pneumothorax develops 2

Diagnostic Tools

  • Pleural manometry demonstrates abnormal lung expansion during drainage and can identify non-expandable lung during initial pleural drainage 2, 3
  • Radiological imaging shows abnormal visceral pleural thickening 2
  • Air-contrast chest CT provides definitive visualization 4
  • Ultrasound M-mode measurement of lung movement shows promise for pre-thoracentesis diagnosis (AUC 0.81) 7

Management Implications

The British Thoracic Society recommends that indwelling pleural catheters (IPCs) are effective at controlling symptoms in non-expandable lung and should be considered as the preferred management technique. 5

Treatment Algorithm Based on Degree of Non-Expansion

For radiologically significant (>25%) non-expandable lung:

  • Use IPC rather than talc pleurodesis 5
  • IPCs work for both expandable and non-expandable lung, making them suitable when lung expansion status is uncertain 5

For <25% non-expandable lung:

  • Talc slurry pleurodesis may improve quality of life, chest pain, breathlessness and pleurodesis rates 5

For trapped lung (chronic, stable effusion):

  • Most patients are asymptomatic or have mild exertional dyspnea and do not require treatment 4
  • Decortication surgery may be considered for incapacitating dyspnea in selected patients fit for thoracic surgery 5, 4

Key Clinical Pitfall

Early evaluation of pleural effusions is critical to address underlying causes of pleural inflammation and prevent progression from lung entrapment (potentially reversible) to trapped lung (irreversible). 1 Delayed intervention allows active pleural disease to mature into an irreversible fibrous peel.

References

Research

Unexpandable lung from pleural disease.

Respirology (Carlton, Vic.), 2018

Research

The unexpandable lung.

F1000 medicine reports, 2010

Research

Unexpandable lung.

Archivos de bronconeumologia, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Malignant Pleural Effusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.